Aardvark Therapeutics (AARD) Non-Current Assets (2024 - 2026)
Aardvark Therapeutics (AARD) reported Non-Current Assets of $5.0 million for Q1 2026, up 102.75% on a YoY basis from $2.5 million in Q1 2025, and down 5.38% sequentially from $5.3 million in Q4 2025.
Aardvark Therapeutics (AARD) Non-Current Assets (2024 - 2026) Analysis & Trends
Aardvark Therapeutics (AARD) has 3 years of Non-Current Assets data on file, last reported at $5.0 million in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Assets rose 102.75% year-over-year to $5.0 million; the trailing twelve-month figure through Mar 2026 stood at $17.0 million (changed N/A YoY), and the FY2025 full-year result was $5.3 million, up 57.12% from the prior year.
- Non-Current Assets retreated to $5.0 million in Q1 2026, from $5.3 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $5.3 million in Q4 2025 to a low of $2.5 million in Q1 2025.
- A 3-year average of $3.8 million and a median of $3.7 million in 2024 frame the typical range for Non-Current Assets.
- Across the five-year window, Non-Current Assets soared 57.12% in 2025 and soared 102.75% in 2026, its largest moves.
- Tracing AARD's Non-Current Assets over 3 years: stood at $3.4 million in 2024, then soared by 57.12% to $5.3 million in 2025, then dropped by 5.38% to $5.0 million in 2026.
- Business Quant data shows AARD's Non-Current Assets at $5.0 million in Q1 2026, $5.3 million in Q4 2025, and $4.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 21.65 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 5.83 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.95 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 3.95 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.66 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.96 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 285.82 Mn |
| 10 | Aardvark Therapeutics | 139.40 Mn | 19.44 Mn | - | 5.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.01 Mn |
| Dec 31, 2025 | 5.30 Mn |
| Sep 30, 2025 | 4.02 Mn |
| Jun 30, 2025 | 2.71 Mn |
| Mar 31, 2025 | 2.47 Mn |
| Dec 31, 2024 | 3.37 Mn |